S Ziegler

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi request reprint Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients
    S Ziegler
    Department of Angiology, University Hospital School of Medicine, Vienna, Austria
    Platelets 13:493-7. 2002
  2. ncbi request reprint Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients
    S Ziegler
    Department of Angiology, University Hospital School of Medicine, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Ann Hematol 83:92-4. 2004
  3. ncbi request reprint Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis
    S Ziegler
    Division of Angiology, Clinic for Internal Medicine II, University Hospital School of Medicine, Vienna, Austria
    Scand J Rheumatol 32:343-7. 2003
  4. ncbi request reprint Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago
    S Ziegler
    Department of Internal Medicine II, Division of Angiology, University of Vienna Medical School, Allgemeines Krankenhaus, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Thromb Res 101:23-33. 2001
  5. pmc Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation
    M Brunner
    Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Vienna, Austria
    Br J Clin Pharmacol 61:31-8. 2006
  6. pmc Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
    R Stoffel
    Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland
    Proc Natl Acad Sci U S A 96:698-702. 1999

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients
    S Ziegler
    Department of Angiology, University Hospital School of Medicine, Vienna, Austria
    Platelets 13:493-7. 2002
    ..In patients suffering from peripheral arterial occlusive disease (PAOD) the risk of restenosis after percutaneous transluminal angioplasty (PTA) might be influenced by platelet mediated factors...
  2. ncbi request reprint Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients
    S Ziegler
    Department of Angiology, University Hospital School of Medicine, Waehringer Guertel 18 20, 1090 Vienna, Austria
    Ann Hematol 83:92-4. 2004
    ..Our results indicate that the effect of ASA on platelet aggregation, as measured by the PFA-100, is not relevantly influenced in PAOD patients with elevated CRP...
  3. ncbi request reprint Long-term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12-year retrospective patient analysis
    S Ziegler
    Division of Angiology, Clinic for Internal Medicine II, University Hospital School of Medicine, Vienna, Austria
    Scand J Rheumatol 32:343-7. 2003
    ..To determine the frequency of development of connective tissue disease (CTD) in patients considered to have idiopathic Raynaud's phenomenon (RP) > 10 years...
  4. ncbi request reprint Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago
    S Ziegler
    Department of Internal Medicine II, Division of Angiology, University of Vienna Medical School, Allgemeines Krankenhaus, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
    Thromb Res 101:23-33. 2001
    ..We investigated the impact of the extent of primary deep venous thrombosis (DVT) and recurrent thrombotic events in accordance to other presumed prognostic factors for long-term clinical outcome after first DVT...
  5. pmc Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation
    M Brunner
    Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Vienna, Austria
    Br J Clin Pharmacol 61:31-8. 2006
    ....
  6. pmc Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo
    R Stoffel
    Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland
    Proc Natl Acad Sci U S A 96:698-702. 1999
    ....